Use of the modified myocardial performance index for evaluating fetal cardiac functions in pregestational diabetic pregnancy babies
No Thumbnail Available
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The aim of this study is assessment of importance of use of the modified myocardial performance index (Mod-MPI) for the evaluation of foetal cardiac function in foetuses of women with pregestational diabetes mellitus (PDM). In this study, data of 30 pregnant patients aged 18–45 years diagnosed with PDM and 30 pregnant women aged 18–45 years with normal pregnancy and their babies were evaluated. Foetal echocardiographic and doppler measurements, foetal biometric measurements, umbilical artery and ductus venosus pulsatility indexes were measured in both PDM and control groups. The Mod-MPI was significantly higher in foetuses of PDM women. Many influences especially cardiac and postpartum complications are observed in infants of PDM women. The Mod-MPI is a simple and useful method for assessing foetal ventricular function. Our study has shown that PDM is associated with foetal ventricular dysfunction.Impact statementWhat is already known on this subject? Although MPI is frequently used in routine clinical assessment of neonates, it is not used adequately in foetuses. Many influences especially cardiac and postpartum complications are observed in infants of PDM women. However, there are few studies focussed specifically on the assessment of foetal cardiac function in PDM. What do the results of this study add? MPI, which shows both diastolic and systolic functions is independent of ventricular anatomy and foetal heart rate, was found significantly higher in diabetic mother foetuses, can be said to be a valuable parameter in evaluating foetal cardiac functions globally. What are the implications of these findings for clinical practice and/or further research? Our study has shown that foetuses PDM are associated with foetal ventricular dysfunction. For this MPI measurement can be routinely performed at foetal cardiac measurements in foetuses of PDM mothers. © 2020 Informa UK Limited, trading as Taylor & Francis Group.
Description
Keywords
Adult , Biometry , Diabetes Mellitus , Echocardiography, Doppler , Female , Fetal Heart , Gestational Age , Humans , Pregnancy , Pregnancy Complications , Pregnancy in Diabetics , Pulsatile Flow , Ultrasonography, Prenatal , Umbilical Arteries , Umbilical Veins , Ventricular Dysfunction , insulin , A wave , adult , Apgar score , Article , ascending aorta , birth weight , blood pressure measurement , cardiac index , cesarean section , clinical article , color Doppler flowmetry , controlled clinical trial , controlled study , diabetes mellitus , diet therapy , echocardiography , female , fetus , fetus function test , fetus movement , fetus myocardium , fractional shortening , gestational age , heart ejection fraction , heart function , heart left ventricle enddiastolic diameter , heart left ventricle endsystolic diameter , heart performance , human , hypoglycemia , insulin dependent diabetes mellitus , insulin treatment , interventricular septum , maternal age , meconium aspiration , modified myocardial performance index , neonatal intensive care unit , neonatal respiratory distress syndrome , newborn , non insulin dependent diabetes mellitus , pregnancy , pregnancy diabetes mellitus , pregnant woman , priority journal , prospective study , puerperal infection , pulsatility index , tachycardia , umbilical artery , vaginal delivery , biometry , diabetes mellitus , diagnostic imaging , Doppler echocardiography , fetus echography , fetus heart , heart ventricle function , pathophysiology , pregnancy , pregnancy complication , pregnancy diabetes mellitus , procedures , pulsatile flow , umbilical artery , umbilical vein